The PFN1 gene helps cells build and reshape their internal scaffolding, which supports cell shape, movement, and the long branches of nerve cells. When this gene does not work properly, that support system can become unstable. Some people with harmful PFN1 variants develop a rare inherited form of amyotrophic lateral sclerosis, which causes progressive muscle weakness, and some variants are linked to uncommon bone conditions. PFN1 is mainly known in genetics and neurology rather than through major public media stories.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate processes in the body. Some genes contain the directions for producing proteins, which are the working parts of cells. Other genes mainly help control when certain processes happen, where they happen, and how strongly they run. Together, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
PFN1Gene function
What if the gene works
The PFN1 gene helps cells build and remodel actin, a key part of their internal framework. This supports cell shape, movement, and division. It also helps nerve cells maintain their long extensions.
Risk
What if the gene does not work
Variants in the PFN1 gene are best known for causing some inherited forms of ALS and, less often, Paget disease of bone. Milder and more severe variants can affect when symptoms begin, how fast weakness progresses, and which features appear.
Treatment
What does that mean for your treatment
At present, no treatment or management approach specific to the PFN1 gene is established in clinical guidelines. In ALS research, the PFN1 gene is being studied to understand protein clumping and changes in nerve cell structure, which may help future drug development.
Gene function
What if the gene works
Your cells need a flexible inner framework to keep their shape, move, and divide. The PFN1 gene helps control this framework by managing actin, a major protein that forms tiny support fibers. This is a key part of what the PFN1 gene does in the body each day.
PFN1 holds actin building blocks and helps place them onto growing fibers. This gives cells a controlled way to build the internal strands they use for structure and motion.
By directing actin growth near the cell surface, PFN1 helps cells spread, reach, and move in a coordinated way. This supports everyday tasks such as wound healing and immune cell travel.
PFN1 helps cells adjust their internal tension as they attach, flatten, or squeeze through tight spaces. This keeps the cell surface organized and responsive.
During division, PFN1 helps form actin structures that let one cell reshape itself and separate into two. This supports steady tissue growth and renewal.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most variants in the PFN1 gene change the shape or stability of profilin 1, so it may bind less well to actin and other cell partners or become more likely to clump inside cells. Some are milder and only partly reduce activity, while more severe variants can more strongly disrupt folding or promote clumping. This shows how PFN1 gene variants affect protein function and, in ALS linked to the PFN1 gene, may influence how early symptoms start.
How variants are linked to conditions
Pathogenic variants in the PFN1 gene are a confirmed cause of a rare inherited form of amyotrophic lateral sclerosis, also called ALS. In families affected by PFN1 gene variants linked to ALS, the pattern is usually autosomal dominant, so the condition can run from one generation to the next. Not every change in the PFN1 gene is harmful, and common variants are not used to diagnose typical ALS.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely found across the population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, one specific, well-understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the PFN1 gene. For many living with a PFN1 gene change, risk depends most on the exact variant and family history, and a doctor or genetic counselor can help explain what that may mean.
Inheritance of PFN1 variants
PFN1 gene inheritance for the best-established PFN1-related condition follows an autosomal dominant pattern. This means a parent with a disease-causing PFN1 variant can pass it to a son or daughter, and each child has a 50% chance of inheriting that variant. Men and women can inherit it and pass it on equally because the PFN1 gene is on one of the numbered chromosomes, not a sex chromosome. Not everyone who inherits a PFN1 variant will have the same symptoms or the same course over time.
What does my PFN1 result mean for my family?
For PFN1, the best-known family pattern is dominant, which means a harmful change can run through several generations. Close relatives such as parents, brothers, sisters, and children may also carry the same change and could have a higher chance of developing a related nerve condition like ALS. Family testing discussions often focus first on first-degree relatives.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the PFN1 gene usually uses a blood or saliva sample. A lab reads the PFN1 gene with sequencing, often as part of an inherited ALS panel, to look for variants and then classifies any change by how likely it is to be linked with disease.
When should I consider getting a genetic test?
Genetic testing for the PFN1 gene may be worth considering if you or close relatives have ALS, especially when more than one family member is affected or symptoms started at a younger age. A PFN1 result can help explain whether the condition may run in the family and support genetic counseling for relatives.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but what they show depends on the condition and the kind of variant involved. Many other factors also shape how the body works over time, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it differently because their bodies can absorb, break down, transport, or respond to a drug in different ways. This is common and can influence how well a medicine works or how sensitive someone is to side effects. In practice, genetics is one part of the picture alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medications. It looks at connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the PFN1 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or dose at this time, so general questions about side effects, new symptoms, or how medicines may affect your health are best discussed with your doctor or pharmacist.
History
Scientists first identified the PFN1 gene during studies of the cell’s internal support system in the late 20th century, as researchers worked to understand how cells keep their shape and move. Initially understood only through visible traits, later recognized as tied to a specific gene, PFN1 became part of a broader effort to map the proteins that organize the cell’s inner framework. A major turning point came in 2012, when rare inherited variants in the PFN1 gene were linked to some families with amyotrophic lateral sclerosis, also called ALS. From these first observations, research expanded steadily. That discovery placed PFN1 into the history of neurogenetics and opened new lines of study into inherited forms of motor neuron disease.